Dr. Monique M. Chouraeshkenazi leads The Chouraeshkenazi Group in offering specialized mental health services blending clinical neuropsychology with forensic science. Tysons Corner, VA, USA, October 17, 2025 — Bridging Mental Health and Forensic Neuropsychopathology: The… Read More »The Chouraeshkenazi Group Announces Leadership in Forensic Neuropsychopathology
HONG KONG, Oct. 17, 2025 /PRNewswire/ — The Hong Kong Monetary Authority (HKMA), in collaboration with the Hong Kong Cyberport Management Company Limited (Cyberport), announced on 15 October the second cohort of the Generative… Read More »Ant Digital Technologies Joins HKMA GenA.I. Sandbox as Technology Partner
GreenBanana SEO delivers a disciplined, outcomes-first approach to pay-per-click management designed to turn ad spend into dependable revenue. Beverly, Massachusetts, United States, October 17, 2025 — GreenBanana SEO delivers a disciplined, outcomes-first approach to pay-per-click… Read More »GreenBanana SEO Serves as Leading PPC Management Agency for Businesses
Revise, Inc. is helping homeowners take control of their energy use through comprehensive Home Energy Audits in Wayland. Wayland, Massachusetts, United States, October 17, 2025 — Revise, Inc. is helping homeowners take control of their… Read More »Revise, Inc. Drives Efficiency with Comprehensive Home Energy Audits in Wayland
Revise, Inc., a leader in home energy solutions, offers homeowners the opportunity to significantly lower utility expenses and increase comfort through comprehensive Home Energy Assessments in Wayland. Wayland, Massachusetts, United States, October 17, 2025 —… Read More »Revise, Inc. Helps Homeowners Unlock Energy Savings with Expert Home Energy Assessments in Wayland
RepIntel reimagines pharmaceutical outreach as a core layer of global health infrastructure, converting field operations into a responsive intelligence network that channels lifesaving therapies to the patients and populations who need them most. New York,… Read More »Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies